======= ST8SIA6 ======= == Gene Information == * **Official Symbol**: ST8SIA6 * **Official Name**: ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=338596|338596]] * **UniProt**: [[https://www.uniprot.org/uniprot/P61647|P61647]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ST8SIA6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ST8SIA6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610139|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the glycosyltransferase 29 protein family. Members of this protein family synthesize sialylglycoconjugates. Sialylation may contribute to multidrug resistance in cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]. * **UniProt Summary**: Prefers O-glycans to N-glycans or glycolipids as acceptor substrates. The minimal acceptor substrate is the NeuAc- alpha-2,3(6)-Gal sequence at the non-reducing end of their carbohydrate groups (By similarity). {ECO:0000250}. |Glyco transf 29| |ganglioside biosynthetic process| |sialyltransferase activity| |ganglioside metabolic process| |sialylation| |glycosphingolipid biosynthetic process| |hatching| |organism emergence from protective structure| |blastocyst hatching| |ceramide biosynthetic process| |oligosaccharide metabolic process| |glycolipid biosynthetic process| |glycosphingolipid metabolic process| |ceramide metabolic process| |sphingolipid biosynthetic process| |blastocyst development| |glycolipid metabolic process| |liposaccharide metabolic process| |protein O-linked glycosylation| |carbohydrate biosynthetic process| |membrane lipid biosynthetic process| |sphingolipid metabolic process| |membrane lipid metabolic process| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |in utero embryonic development| |glycoprotein metabolic process| |carbohydrate metabolic process| |amide biosynthetic process| |lipid biosynthetic process| |carbohydrate derivative biosynthetic process| |Golgi membrane| |chordate embryonic development| |embryo development ending in birth or egg hatching| |cellular amide metabolic process| |cellular lipid metabolic process| |embryo development| |carbohydrate derivative metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp477|DKK1 89ng/ml R08 exp477]]|-2.38| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14818 * **Expression level (log2 read counts)**: 0.63 {{:chemogenomics:nalm6 dist.png?nolink |}}